RK-682 CAS: 332131-32-5
MF: (C21H35O5)2•Ca
MW: 775.06
A specific PTP1B inhibitor.

RK-682 (CAS 332131-32-5)

RK-682 | CAS 332131-32-5 is rated 5.0 out of 5 by 1.
  • y_2022, m_1, d_22, h_20
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.20
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_202319, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 106ms
  • REVIEWS, PRODUCT
loading
5
1
4
0
3
0
2
0
1
0
Application: RK-682 is a specific PTP1B inhibitor
CAS Number: 332131-32-5
Purity: >95%
Molecular Weight: 775.06
Molecular Formula: (C21H35O5)2•Ca
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).
DISCOUNT: Bulk orders of Chemicals totaling $1,000 or more receive a 5% discount.
loading

RK-682 is the calcium salt of 3-hexadecanoyl-5-hydroxymethyl-tetronic acid, a naturally-occurring specific inhibitor of protein tyrosine phosphatase (PTPase). specifically PTP1B. RK-682 is reported to inhibit dephosphorylation activity of CD45 (IC50 = 54 microM) and VHR (IC50 = 2.0 microM), and to arrest cell cycle progress at the G1/S transition. Studies with RK-682 and derivatives have demonstrated efficacy in inhibiting HIV-1 protease activity. RK-682 also displays activity against heparanase function, a protein indicated as operative in tumor cell invasion and angiogenesis.


References

1. Roggo, B.E., et al. 1994. J. Antibiot. 47: 136-142. PMID: 8150707
2. Hamaguchi, T., et al. 1995. FEBS Lett. 372: 54-58. PMID: 7556642
3. Ishida, K., et al. 2004. Mol. Cancer Ther. 3: 1069-1077. PMID: 15367701

Physical State :
Solid
Derived From :
Streptomyces sp.
Solubility :
Soluble in ethanol, methanol, DMF, and DMSO.
Storage :
Store at -20° C
IC50 :
CD45 dephosphorylation activity: IC50 = 54 mM; VHR dephosphorylation activity: IC50 = 2 mM
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

RK-682 (CAS 332131-32-5)  Product Citations

See how others have used RK-682 (CAS 332131-32-5). Click on the entry to view the PubMed entry .

Citations 1 to 4 of 4 total

PMID: # 16545563  Na, M. et al. 2006. Bioorg. Med. Chem. Lett. 16: 3061-3064.

PMID: # 15367701  Ishida, K. et al. 2004. Mol. Cancer Ther. 3: 1069-1077.

PMID: # 7556642  Hamaguchi, T. et al. 1995. FEBS Lett. 372: 54-58.

PMID: # 7783960  Fujii, S. et al. 1995. Neurosci. Lett. 187: 133-136.

Citations 1 to 4 of 4 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 93ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Na Na, M. et al. (PubMed 16545563) used RK-682, an inhibitor of protein tyrosine phosphatase (PTP), as a positive control against other potential PTP inhibitors. -SCBT Publication Review
Date published: 2015-06-08
  • y_2022, m_1, d_22, h_20
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.20
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_202319, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 8ms
  • REVIEWS, PRODUCT